By promoting ABCA1-mediated cholesterol efflux, metformin may enhance ApoE lipidation, improving its roles in neuronal repair, synaptic maintenance, and Aβ clearance, thus potentially mitigating AD progression [200]. The gene discussed is ABCA1; the disease is Alzheimer disease.